2 INCOMPLETE AGGLUTININS ASSOCIATED WITH ANTI-LEA IN RABBIT ANTISERA AGAINST GUM ARABIC

被引：2
|
作者：
MATSUZAWA, S
机构：
来源：
VOX SANGUINIS | 1967年 / 13卷 / 03期
关键词：
D O I：
10.1111/j.1423-0410.1967.tb03391.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：218 / +
页数：1
相关论文
共 50 条
  • [21] RABBIT LYMPHOID-CELLS .2. ANTI-ALLOTYPE ANTISERA, LIPOPOLYSACCHARIDE AND OTHER BACTERIAL AND FUNGAL MITOGENS AS PROBES FOR IDENTIFICATION OF B-CELL SUBPOPULATIONS
    SHEK, PN
    CHOU, CT
    DUBISKI, S
    CINADER, B
    IMMUNOLOGY, 1976, 31 (01) : 129 - 138
  • [22] ASSOCIATED STATE OF RABBIT ALLOTYPES, EXISTENCE OF RABBIT ANTIBODY MOLECULES AGAINST 2 ALLOTYPES, AND DISSOCIATION OF HUMAN GAMMA-GLOBULIN ANTIGENS INTO SMALLER MOLECULES
    OUDIN, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1961, 5 (05) : 358 - +
  • [23] SPECIFICITY OF RABBIT ANTISERA AGAINST THE ROUGH LIPOPOLYSACCHARIDE OF SALMONELLA-MINNESOTA R4 (CHEMOTYPE RD2P-) (VOL 61, PG 3217, 1993)
    SWIERZKO, A
    BRADE, L
    PAULSEN, H
    BRADE, H
    INFECTION AND IMMUNITY, 1993, 61 (10) : 4532 - 4532
  • [24] HER2 Intratumoral Heterogeneity Is Associated with Incomplete Response to Anti-HER2 Neoadjuvant Chemotherapy in HER2-Positive Breast Carcinoma
    Li, Zaibo
    Nitta, Hiroaki
    Hou, Yanjun
    Banks, Peter
    MODERN PATHOLOGY, 2017, 30 : 55A - 55A
  • [25] HER2 Intratumoral Heterogeneity Is Associated with Incomplete Response to Anti-HER2 Neoadjuvant Chemotherapy in HER2-Positive Breast Carcinoma
    Li, Zaibo
    Nitta, Hiroaki
    Hou, Yanjun
    Banks, Peter
    LABORATORY INVESTIGATION, 2017, 97 : 55A - 55A
  • [26] COOPERATION BETWEEN SUBCLASSES OF LYMPHOCYTES-T IN THE INVITRO GENERATION OF CYTOTOXICITY AGAINST A MUTANT H-2K DIFFERENCE - ANALYSIS WITH ANTI-LYT ANTISERA
    MELIEF, CJ
    VANDERMEULEN, MY
    CHRISTIAANS, BJ
    DEGREEVE, P
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1979, 9 (01) : 7 - 12
  • [27] HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Yanjun Hou
    Hiroaki Nitta
    Lai Wei
    Peter M. Banks
    Bryce Portier
    Anil V. Parwani
    Zaibo Li
    Breast Cancer Research and Treatment, 2017, 166 : 447 - 457
  • [28] HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Hou, Yanjun
    Nitta, Hiroaki
    Wei, Lai
    Banks, Peter M.
    Portier, Bryce
    Parwani, Anil V.
    Li, Zaibo
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (02) : 447 - 457
  • [29] Fe3O4-Coated CNTs-Gum Arabic Nano-Hybrid Composites Exhibit Enhanced Anti-Leukemia Potency Against AML Cells via ROS-Mediated Signaling
    Halim, Alyaa S. Abdel
    Ali, Mohamed A. M.
    Inam, Fawad
    Alhalwan, Abdulrahman M.
    Daoush, Walid M.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 7323 - 7352
  • [30] DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer
    Menyhart, Otilia
    Budczies, Jan
    Munkacsy, Gyongyi
    Esteva, Francisco J.
    Szabo, Andras
    Puig Miquel, Teresa
    Gyorffy, Balazs
    ONCOTARGET, 2017, 8 (44) : 77207 - 77218
12345